Valuation: Cegedim

Market Cap 14Cr 16Cr 13Cr 12Cr 23Cr 1.57TCr 23Cr 155.71Cr 61Cr 790.77Cr 62Cr 60Cr 2.62TCr P/E 2026 *
6.73x
P/E 2027 * 5.13x
Enterprise Value 30Cr 35Cr 28Cr 26Cr 49Cr 3.37TCr 49Cr 334.93Cr 130.39Cr 1.7TCr 132.78Cr 129.89Cr 5.63TCr EV / Sales 2026 *
0.46x
EV / Sales 2027 * 0.4x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day-56.91%
1 week+16.60%
Current month+19.35%
1 month+19.82%
3 months+4.92%
6 months+0.83%
Current year-9.33%
1 week 10.28
Extreme 10.28
12.15
1 month 10.18
Extreme 10.18
12.15
Current year 8.6
Extreme 8.6
14.8
1 year 8.6
Extreme 8.6
14.8
3 years 8.6
Extreme 8.6
20.75
5 years 8.6
Extreme 8.6
28.8
10 years 8.6
Extreme 8.6
42.5
Manager TitleAgeSince
Chief Executive Officer 83 25/10/2009
Director of Finance/CFO - 14/06/2016
Corporate Officer/Principal 55 26/11/2015
Director TitleAgeSince
Chairman 83 25/10/2009
Director/Board Member 72 09/08/2010
Director/Board Member 55 26/10/2009
Change 5-day change 1-year change 3-year change Capi.($)
-56.91%+16.60% - - 16Cr
+1.62%+1.38%-38.51%+24.73% 41TCr
-0.93%+1.62%-20.40%+47.00% 25TCr
-0.82%+6.29%-27.84%+12.66% 13TCr
-0.65%+2.68%-31.14%+13.05% 4.75TCr
+3.42%+37.08%-63.04%+277.41% 4.71TCr
-2.51%+5.47%-20.14%+33.48% 2.52TCr
+0.25%+5.29%-15.29%+73.34% 2.12TCr
-1.85%+5.95%-10.89%+133.24% 1.6TCr
-2.04%+4.28%-27.02%+13.96% 1.41TCr
Average -6.64%+7.12%-28.25%+69.87% 10.73TCr
Weighted average by Cap. -0.55%+3.78%-31.54%+43.57%

Financials

2026 *2027 *
Net sales 66Cr 77Cr 62Cr 56Cr 106.54Cr 7.34TCr 107.59Cr 728.98Cr 283.79Cr 3.7TCr 289Cr 282.71Cr 12TCr 68Cr 80Cr 64Cr 59Cr 110.49Cr 7.61TCr 111.58Cr 756.06Cr 294.33Cr 3.84TCr 299.74Cr 293.21Cr 13TCr
Net income 2.13Cr 2.49Cr 2Cr 1.82Cr 3.44Cr 236.97Cr 3.47Cr 24Cr 9.16Cr 119.56Cr 9.33Cr 9.13Cr 395.94Cr 2.8Cr 3.27Cr 2.62Cr 2.4Cr 4.52Cr 311.51Cr 4.57Cr 31Cr 12Cr 157.17Cr 12Cr 12Cr 520.48Cr
Net Debt 16Cr 19Cr 15Cr 14Cr 26Cr 1.8TCr 26Cr 179.22Cr 70Cr 910.16Cr 71Cr 70Cr 3.01TCr 13Cr 16Cr 13Cr 11Cr 22Cr 1.49TCr 22Cr 147.83Cr 58Cr 750.75Cr 59Cr 57Cr 2.49TCr
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change Volume
25/26/25 €10.28 -1.34% 0
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.26EUR
Average target price
15.50EUR
Spread / Average Target
+51.07%

Quarterly revenue - Rate of surprise